Dr. Agarwal's Health Care has reported an inter-se transfer of shares between promoter group members, with Dr. Athiya Agarwal acquiring 21,15,180 shares from Dr. Anosh Agarwal on March 4, 2026. The transaction was executed under SEBI's exemption provisions for transfers between immediate relatives.

Transaction Details

The share transfer was completed as a gift transaction between Dr. Anosh Agarwal (transferor) and Dr. Athiya Agarwal (transferee), who are immediate relatives. The acquisition falls under Regulation 10(1)(a)(i) of SEBI (SAST) Regulations, 2011, which provides exemption from mandatory open offer requirements for inter-se transfers among immediate relatives.

Shareholding Changes

The transaction resulted in changes to individual shareholdings within the promoter group while maintaining the overall promoter group stake. Dr. Athiya Agarwal's shareholding increased significantly, while Dr. Anosh Agarwal's holding decreased proportionally.

Regulatory Compliance

The company fulfilled all regulatory requirements associated with the transaction. Prior intimation under Regulation 10(5) was filed on February 24, 2026, within the specified timeline. The post-transaction disclosure under Regulation 10(6) was submitted to both BSE and NSE on March 5, 2026.

The transaction maintains compliance with SEBI regulations as it involves immediate relatives within the promoter group, ensuring no change in the total promoter and promoter group shareholding of the target company. The shares are listed on BSE Limited with company code 544350 and National Stock Exchange of India Limited with symbol AGARWALEYE.

Dr. Agarwal's Health Care Limited has received a regulatory report from Dr. Athiya Agarwal under SEBI SAST Regulation 10(6) confirming the completion of an inter-se share transfer. The transaction, completed on February 24, 2026, involved the acquisition of 14,85,822 shares representing 0.47% of the company's share capital through a gift transfer from Dr. Anosh Agarwal.

Transaction Completion Details

The completed share transfer represents an inter-se transfer between promoter group members who are immediate relatives. Dr. Athiya Agarwal filed the regulatory report on February 26, 2026, with both BSE Limited and National Stock Exchange of India Limited, confirming the completion of the previously disclosed transaction.

Regulatory Compliance Framework

The transaction was executed under the exemption provided in Regulation 10(1)(a)(i) of SEBI SAST Regulations, 2011, which covers inter-se transfers of shares amongst immediate relatives. Dr. Athiya Agarwal had previously filed the required prior intimation under Regulation 10(5) on February 6, 2026, within the specified timeline.

Updated Shareholding Pattern

The inter-se transfer has resulted in changes to individual shareholdings within the promoter group while maintaining the overall promoter group shareholding percentage. The regulatory filing confirms that there has been no change in the total shareholding of the promoter and promoter group after the inter-se transfer.

Stock Exchange Notification

The regulatory report was filed with both BSE Limited (Company Code: 544350) and National Stock Exchange of India Limited (Company Symbol: AGARWALEYE). The filing confirms that all disclosure requirements under SEBI SAST Regulations have been fulfilled, including the prior intimation and post-transaction reporting obligations.

The completed transaction represents a straightforward reorganization of shareholding within the promoter group, with no impact on the company's operational structure or public shareholding pattern. The gift transfer eliminates the requirement for making an open offer to public shareholders under the immediate relatives exemption provision.